Effects of co-supplementation of chromium and magnesium on metabolic profiles, inflammation, and oxidative stress in impaired glucose tolerance
Diabetes and Vascular Disease Research · 2024
DOI: 10.1177/14791641241228156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes and Vascular Disease Research, 2024. Verfasst von Yang Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Affiliated Qingdao Central Hospital, Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Glucose Intolerance, Insulin Resistance. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Purpose
To evaluate the effects of chromium (Cr) and magnesium (Mg) ions on metabolic profiles, inflammation, and oxidative stress with impaired glucose tolerance (IGT) and insulin resistance (IR).
Methods
120 individuals with IGT and IR were randomly divided into four groups treated with (1) chromium, (2) magnesium, (3) chromium and magnesium or (4) placebo. Metabolic and inflammatory indicators were measured at baseline and after 3 months intervention.
Results
Comparison among groups showed that fasting plasma glucose (FPG), 2 h post glucose (2hPPG), fasting insulin (FINS) and homeostatic model assessment for insulin resistance (HOMA-IR) in Cr + Mg group were significantly decreased compared with the other three groups ( p < .05), and high density lipoprotein (HDL-c) levels were higher. 8-iso prostaglandin F2 alpha (8-iso-PGF2a) decreased in Cr, Mg, and Cr + Mg groups compared with placebo ( p < .05), and 8-iso-PGF2a decreased in Cr + Mg groups compared with Cr group and Mg groups ( p > .05). Intra-group comparison showed that the levels of FPG, 2hPPG and FINS in Cr + Mg group were significantly decreased after intervention ( p < .05), and FINS in Mg group was significantly decreased ( p < .01). The levels of HDL-c and triacylglycerol (TG) in Cr + Mg group were significantly improved ( p < .05). The level of HDL-c in Mg group was significantly improved compared with baseline ( p < .05). Compared with baseline, high-sensitivity C-reactive protein (hsCRP) levels in Cr + Mg group and Mg group were significantly decreased ( p < .05).
Conclusions
The co-supplementation of Cr and Mg improves glycemic and lipid levels and reduces the inflammatory response and oxidative stress profiles of individuals with impaired glucose tolerance and insulin resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Affiliated Qingdao Central Hospital, Qingdao University, Qingdao, China.
- Department of Endocrinology, NingJin County People's Hospital, Xingtai, China.
- College of Medicine, Qingdao University, Qingdao, China.
- Department of Pharmacy, Qingdao Central Hospital, Qingdao, China.
ORCID-Profile: Yang Zhao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhao, Y., Zhou, M., Shang, Y., Dou, M., Gao, S., Yang, H., & Zhang, F. (2024). Effects of co-supplementation of chromium and magnesium on metabolic profiles, inflammation, and oxidative stress in impaired glucose tolerance. Diabetes and Vascular Disease Research. https://doi.org/10.1177/14791641241228156
Vancouver
Zhao Y, Zhou M, Shang Y, Dou M, Gao S, Yang H, et al. Effects of co-supplementation of chromium and magnesium on metabolic profiles, inflammation, and oxidative stress in impaired glucose tolerance. Diabetes and Vascular Disease Research. 2024. doi:10.1177/14791641241228156
BibTeX
@article{Zhao2024,
author = {Zhao, Yang and Zhou, Mengmeng and Shang, Yongfang and Dou, Mei and Gao, Shan and Yang, Hai and Zhang, Fanghua},
title = {Effects of co-supplementation of chromium and magnesium on metabolic profiles, inflammation, and oxidative stress in impaired glucose tolerance},
journal = {Diabetes and Vascular Disease Research},
year = {2024},
doi = {10.1177/14791641241228156}
}
EUVIMED